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Background
Young injection drug users (IDU) are at high 
risk for viral infections, such as HIV, hepatitis 
C virus (HCV), and hepatitis B virus (HBV), due 
to frequent injecting, needle/syringe and other 
drug preparation equipment sharing, high 
numbers of sexual partners, and exchange of 
sex for money or drugs. Street youth who inject 
have high unemployment, poor education, and 
mental health issues.
In San Francisco, young IDU are typically 
homeless runaways who often are involved in 
an illegal street economy, including prostitution, 
drug sales, theft, panhandling, pornography 
and selling stolen property. They experience 
a large number of negative and traumatic 
events prior to leaving home. Many fear and 
mistrust authority and consequently avoid or 
delay contact with the public health system. The 
combination of youth, drugs, survival sex and 
disenfranchisement make this group extremely 
vulnerable to multiple negative health outcomes.
Why this program?
UFO Presents! is a Center for Disease Control 
and Prevention (CDC)-funded program providing 
much needed hepatitis education, prevention 
and care services for youth and young adults 
with injection risk in San Francisco, CA. We 
aim to meet the broader needs of youth and 
young adults through comprehensive health 
and psychosocial support. We are the most 
experienced group in San Francisco in providing 
hepatitis, HIV and STI prevention services 
tailored to young adult IDU, a group with few 
other health-related resources or programs 
tailored directly to them.
UFO Presents! follows from a series of research 
studies with young IDU, called the UFO Studies. 
Since 1997, UFO has served over 1200 young 
IDU in San Francisco. HCV prevention care 
education resources have been offered to 
UFO participants. UFO Presents! allows us to 
apply our years of experience to ALL young IDU, 
regardless of participation in the UFO Studies. 
Educating young IDU
The UFO research studies of HIV, STIs and 
viral hepatitis have developed comprehensive 
hepatitis B and C testing and counseling. We 
promote HBV immunizations and risk reduction 
from bloodborne viral infections, HIV testing and 
counseling training, and base our work on  CDC 
guidelines with input from community groups. 
Our education protocols are drawn from 
published materials and public sources, but 
we have modified the delivery to capture the 
interest of and appeal to our target population. 
This includes utilizing peer leaders in sessions, 
one-on-one ‘individual’ time with the nurse 
educator and addressing common questions 
and issues that arise among this community.  
UFO has developed important information on 
prevention among those living with HCV and 
education regarding HCV treatment for both 
acute and chronic infection. UFO Presents! 
uses over 10 years of research on young drug 
users to inform this program in an established, 
proven system for success in providing hepatitis 
information and testing. 
UFO Presents! services              
Eligible participants
All injection drug users under age 30, 
regardless of HCV status.
Program 
sites and 
hours  
We have 
established 
regular hours 
for drop-in 
and follow 
up at community-based sites in neighborhoods 
frequented by young IDU. 
Sites are staffed by nurses, test counselors, 
outreach workers, a phlebotomist, volunteer 
clinicians and a field supervisor.  
Project sites are open weekly daytime and 
evening hours 52 weeks a year, including 
all holidays; no appointments are needed. 
Participants can reach staff through a 24-hour 
hotline in addition to visiting during site hours.
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2nd and 4th Thursday of every month   
12:30 – 4:30pm 
Homeless Youth Alliance, 1696 Haight Street     
Viral hepatitis prevention education
We offer a weekly viral hepatitis prevention 
education group led by a Clinical Nurse 
Specialist. Peer educators offer experience 
and support, while nursing staff provides 
information and education. Topics covered 
include Hep C 101, Liver Health for the Active 
Drug Users, Hepatitis B, Hep C and Mental 
Health, Treatment Eligibility and Transmission 
Prevention. Participants are encouraged to 
meet with nursing staff for individualized care 
plans and education. Food and snacks are 
served at the beginning of group. 
“UFO made me much more aware of where  
I took risks and didn’t. Counseling helped  
me recognize the patterns”
Immunizations
Free HAV and HBV vaccinations are available to 
all participants. Our electronic database records 
date of vaccine administration and tracks when 
the next one is due. E-mails can be generated 
to remind participants to drop in for next 
immunization. Street and office-based outreach 
workers are available to help participants 
return. We offer referrals to similar programs 
outside of the Bay Area for youth who are 
frequent travelers to facilitate vaccine uptake.
“Everything I know about HCV I learned  
from UFO”
HIV, HBV, HCV and other STD testing
Through partnerships with the Berkeley Free
Clinic and SFDPH, we offer on-site counseling
and testing for HIV, HCV and STIs. Our 
experienced HIV-trained counselors perform risk
assessments and provide client-centered risk
reduction counseling. Testing includes HIV, anti-
HCV, LFTs, viral load, as well as HAV and HBV
immunological status. We promote and support
harm reduction services. Outreach workers are
available to remind participants to return for
testing results. Referrals for further workups
and appropriate medical treatment is available
through program staff.
“I got good counseling. Someone sat with  
me while I cried. There were no judgments 
about my addiction. The staff consistently 
shows compassion.”
Medical care
Our nurses have many years of experience 
working with young IDU and have a strong 
understanding of the particular health needs 
and concerns of this group. Staffed by a nurse 
practitioner, a clinical nurse specialist, and 
an RN, our nurses are available for medical 
consultation, referrals to other medical clinics 
or mental health care. We also provide acute 
care such as treatment of infections, including 
abscess care, common respiratory infections, 
rashes and other basic acute medical needs.
“I like the interaction with the staff and  
the family feel.”
Drug treatment referrals
Direct referrals to methadone and 
buprenorphine programs are available to those 
interested, as well as access to residential 
treatment programs or other programs tailored 
for drug users. We work to find the program 
best suited to participants’ needs. We provide 
referrals and advocacy and work closely with 
participants before program entry, during 
program participation and after program 
completion.
“I got a referral to get on suboxone and  
my HCV results for the first time.”
Housing and social work referrals
We offer referrals and support for access to 
housing and other social services, including SSI 
eligibility, educational and vocational programs 
as well as maternal-child services. We will work 
with case managers or other providers of care 
for program participants to optimize their ability 
to access supportive services.
Syringe exchange
A syringe exchange program operates on site 
to provide clean needles and other injection 
equipment such as cookers, sterile water and 
tourniquets. We train clients how to prevent 
and manage overdose situations and provide 
prescriptions for Narcan.
“I learned about injection hygiene. Because  
of you, I haven’t gotten an abscess.”
Quality of life services
We provide free food, clothes, socks and 
hygiene supplies (soap, shampoo, razors, etc.) 
on site, whenever possible. At our sites, young 
IDUs can access the Internet, use a telephone 
for free, and receive mail.  
Our community partners
We have established linkages with community 
health-care providers including:
San Francisco Department of Public Health • 
(SFDPH) Adult Immunization program
Saint Anthony Free Medical Clinic• 
Tenderloin Health• 
We have a close partnership with 
San Francisco Needle Exchange (SFNE) • 
Homeless Youth Alliance (HYA)• 
Berkeley Free Clinic• 
Housing and Urban Health Clinic• 
SFDPH AIDS Office• 
The UFO Studies
1997-1999: The first “UFO Study” assessed 
the  prevalence of HIV, HBV and HCV infections. 
We showed high seroprevalence of HCV and 
reported on HIV and risk factors. 
2000-2002: We next began to study young 
IDU prospectively (UFO-3 Study). We assessed 
HIV and HCV incidence and HBV immunization 
feasibility conducted over a 2½ year period. 
We showed a high rate of HCV seroconversion 
(25% per year) and identified important risk 
factors for HCV seroconversion, including 
sharing ancillary injecting equipment. We 
tested adherence to and effectiveness of an 
accelerated HBV vaccine schedule. We found 
that HIV infection among young male IDU was 
highly associated with sex work. We also found 
high rates and risk factors for overdose and we 
explored gender-related risks. 
2002-2008: In 2002, we began more in-depth 
studies of HCV infection (UFO Acute HCV Study). 
Using a novel testing algorithm combining 
antibody and viral tests, we identify young 
IDU in the very early or acute phase of HCV 
infection. This phase is very important for many 
reasons: antibody to HCV does not develop for 
up to 2 months following infection but HCV virus 
levels can be very high and risk for transmission 
is high. Some people with HCV will clear or get 
rid of HCV virus and assessing infection early 
allows us to study factors that are associated 
with viral clearance.  Our group demonstrated 
the utility of this testing approach for identifying 
acute and serosilent HCV, and how it can help 
prevention.  
Who did we reach?
UFO participants are all recruited by •	
street-based outreach in locales and 
neighborhood throughout San Francisco 
where young IDU hang out
1,191 young IDU were screened and •	
interviewed between 2000-2007
Over 500 were hepatitis C negative and •	
invited to participate in follow-up study
50% of participants were 22 years old; •	
they ranged from 15 to 29
The majority (70%) were male•	
O• nly 30% reported stable housing in the 
prior 3 months  
Injection drug use
50% of young IDU in UFO had been •	
injecting for 4 years   
More than one-third (36%) reported daily •	
injection drug use in the last 30 days with 
a median of 3 injections per day
78% had ever shared a syringe•	
Nearly half (43%) borrowed a used syringe •	
in the prior 3 months
76% had shared other injecting equipment, •	
such as cookers or rinse, in the last 3 
months
88% used at least 1 of several needle •	
exchange venues in the last 30 days 
Drug treatment
Almost two-thirds (63%) had a history of •	
drug treatment 
Only 13% had participated in drug •	
treatment in the prior 3 months
Hepatitis C
Almost half (45%) of young IDU screened •	
by UFO have antibodies to HCV, indicating 
previous or current infection
HCV incidence is very high: 27% per year•	
20% of young IDU who get infected with •	
HCV spontaneously resolve the infection, 
but many of these get re-infected
HIV
HIV prevalence is lower than HCV •	
prevalence at 5.3%
The majority (88%) of HIV infections •	
detected in UFO participants are in males
HIV prevalence was highest among male •	
IDUs who have sex with men
Hepatitis B
21% had been infected with HBV •	
HBV immunizations are still needed •	
among young IDU: 
 Only 22% of participants had been •	
previously vaccinated
 More than half (56%) were susceptible •	
and	could	benefit	from	vaccine  
Gender differences
Female	IDUs	were	significantly	younger	•	
than males 
Females were more likely to engage in •	
needle borrowing, sharing cookers or 
rinse, and being injected by someone else
Females were more likely than males to •	
report recent sexual intercourse and to 
have IDU sex partners 
Incarceration
Most (85%) young IDU had a history of •	
incarceration (jail or prison)
More than half (56%) had been •	
incarcerated in the prior year
HBV	and	HCV	infections	were	significantly	•	
higher among those with any history of 
incarceration (29% and 42% respectively) 
compared with those with no incarceration 
history
Overdose
22% reported a heroin overdose in the last •	
year
Three-fourths (73%) had ever witnessed •	
a heroin-related overdose, and half (50%) 
had witnessed an overdose in the last 12 
months
14% of those who had witnessed an •	
overdose in the past year reported that the 
outcome of the overdose was death
Significant	findings	from	the	UFO	Studies
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We have followed 368 young IDU at risk of 
HCV and detected 135 new infections, which 
shows that HCV incidence is still high (27% per 
year). Overall, 21% of participants with new 
HCV cleared virus spontaneously, but women 
were three times more likely to clear than men; 
35% compared to 12%. This is an important 
new area to study in order to understand more 
about this infection. We also found that a high 
proportion of young IDU who clear the virus, get 
reinfected and many re-clear again. 
We continue to study immune factors in 
early infection, transmission factors between 
injecting partners and feasibility of treatment for 
young IDU with acute HCV. We have assessed 
other  important disease and drug related 
issues: HBV infection and immunization rates; 
methamphetamine use; risk behaviors among 
traveling young IDU and factors associated with 
stopping injecting and relapsing.
UFO Presents! staff
Kimberly Page PhD MPH; Principal 
Investigator
Dr. Page is Associate Adjunct Professor 
of Medicine in the UCSF Department of 
Epidemiology and Biostatistics, Center for AIDS 
Prevention Studies. She is an epidemiologist 
and is the PI of various studies investigating 
transmission and acquisition of bloodborne 
and sexually transmitted infections in high risk 
populations
Paula Lum MD MPH; Co-Investigator
Dr. Lum is Assistant Professor in Residence 
at the UCSF Positive Health Program at San 
Francisco General Hospital and the Department 
of Medicine at UCSF. She conducts clinical 
research on the epidemiology, prevention and 
treatment of HIV and hepatitis IDU. She is a 
Co-Investigator and medical director for UFO 
Presents!, as well as PI of several studies on 
medical treatment of IDU. 
Peter Davidson PhD(c); Co-Investigator
Peter Davidson has been conducting research 
and harm-reduction based intervention 
development regarding heroin-related 
overdose, hepatitis C transmission and sexually 
transmitted infections among drug users in 
Australia and the US since 1997. From 2002-
2008 he was the project director for the UFO 
Study. He is currently a PhD candidate in the 
medical sociology program in the School of 
Social and Behavioral Sciences at UCSF.
Alice Asher, RN MSN,CNS; Project Director
Alice K. Asher is a Masters-prepared nurse 
with a clinical focus in community health and 
HIV/AIDS. Alice currently serves as the co-
investigator of the “Pain and Substance Use 
Syndromes in an Outpatient Public Health HIV 
Clinic” study and is a research associate, doing 
curriculum development and facilitation for 
nurse capacity-building projects in HIV/AIDS in 
sub-Saharan Africa. 
Alya Briceño; Project Coordinator
Ms. Briceño is an experienced Project 
Coordinator and Study Manager in the Dept. 
of Epi Bio at UCSF.  She has several years of 
culminating experience including community-
based and street-based outreach to young IDU, 
HIV and HCV test counseling and has assisted 
faculty in the implementation of several HIV 
and HCV-related programs and epidemiologic 
studies in San Francisco.
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